ProPhase Labs just filed a General Statement of acquisition of beneficial ownership

The following excerpt is from the company's filing:

Item5.
Interest in Securities of the Issuer
(a)
As of March 3, 2015, BML Investment Partners, L.P., beneficially owned 2,322,327 shares of the Issuer's Common Stock.

As of March 3, 2015, Braden M. Leonard, beneficially owned 2,322,327 shares of the Issuer's Common Stock.

As of March 3, 2015, BML Investment Partners, L.P., beneficially owned 14.6% of the Issuer's Common Stock.

As of March 3, 2015, Braden M. Leonard, beneficially owned 14.6% of the Issuer's Common Stock.

(b)
BML Investment Partners, L.P. has sole voting power over 0 shares, sole dispositive power over 0 shares, shared voting power over 2,322,627 shares and shared dispositive power over 2,322,627 shares.

Braden M. Leonard has sole voting power over 0 shares, sole dispositive power over 0 shares, shared voting power over 2,322,627 shares and shared dispositive power over 2,322,627 shares.
(c)
None
Transaction DateShares or Unites Purchased (Sold)Price Per Share or Unit



(d)
None
(e)
Not Applicable
Item6.
Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer
None
Item7.
Material to Be Filed as Exhibits
None

Signature

The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.

To receive a free e-mail notification whenever ProPhase Labs makes a similar move, sign up!

Other recent filings from the company include the following:

ProPhase Labs's Chief Financial Officer just picked up 360,000 shares - Sept. 15, 2017
Tender offer statement by Issuer - Aug. 25, 2017

Auto Refresh

Feedback